Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding that being a jack of all trades isn’t as valuable to business as excelling at one.
The company makes diagnostic tools to help researchers and drug companies understand what goes wrong in a person’s DNA that causes a cancer to develop, and how well treatments work for each individual. NanoString steered away from trying to develop diagnostics for all types of diseases to instead focus on cancer.
Help employers find you! Check out all the jobs and post your resume.
